Phase 1b/2a safety study of lemborexant as an adjunctive treatment for insomnia to buprenorphine-naloxone for opioid use disorder: A randomized controlled trial

Autor: Martin, Caitlin E., Bjork, James M., Keyser-Marcus, Lori, Sabo, Roy T., Pignatello, Tiffany, Simmons, Kameron, La Rosa, Christina, Arias, Albert J., Ramey, Tatiana, Moeller, F. Gerard
Zdroj: In Drug and Alcohol Dependence Reports March 2025 14
Databáze: ScienceDirect